9:30 am- 9:35 am	Welcome message Dr. Sulie L. Chang, PhD, Professor of Biological Sciences and Director, Institute of Neuroimmune Pharmacology, Seton Hall University, South Orange, NJ, USA
9:35 am- 10:05 am	Special talks, 15 min each Dr. Changhai Cui, PhD, Program Official, Division of Neuroscience and Behavior, National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH, Bethesda, MD, USA Title: COVID-19 and funding opportunities from NIAAA Dr. Yu (Woody) Lin, MD, PhD, Program Official, Integrative Neuroscience Branch (INB), Division of Neuroscience and Behavior (DNB), National Institute on Drug Abuse (NIDA), NIH, Bethesda, MD, USA Title: COVID-19 and funding opportunities from NIDA
Symposium 1: Molecular approaches to COVID-19 pathogenesis and underlying mechanisms Co-chairs: Dr. Changhai Cui, PhD, Program Official, NIAAA, NIH, Bethesda, MA, USA Dr. Pankaj Seth, PhD, Professor and Scientist VII, National Brain Research Centre, Gurgaon, Haryana, India
10:10 am- 10:25 am	Speaker 1: Dr. Rosemarie Booze, PhD, Department of Psychology, University of South Carolina, Columbia, SC, USA Title: Post-acute SARS-CoV-2 infection (PASC) in non-human primate olfactory system and pyriform cortex
10:25 am- 10:40 am	Speaker 2: Dr. Theodore Cory, PharmD, PhD, Department of Clinical Pharmacy and Translational Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA Title: Cellular senescence alters fibrogenesis in SARS-CoV-2 infected macrophage/fibroblast co-cultures
10:40 am- 10.55 am	Speaker 3: Dr. Navneet Dhillon, PhD, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA Title: Assessment of circulating extracellular vesicles reveals pro-inflammatory and thrombosis related protein cargo in COVID-19 patients
10:55 am- 11:10 am	Speaker 4: Dr. Howard Gendelman, MD, Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA Title: SARS-CoV-2 induction of a pro-inflammatory human macrophage
11:10 am- 11.25 am	Speaker 5: Dr. Supriya Mahajan, PhD, Department of Medicine, Division of Allergy, Immunology & Rheumatology Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Clinical Translational Research Center, Buffalo, NY, USA
	Title: Mitochondrial dynamics in SARS-CoV-2 spike protein treated human microglia: Implications for Neuro-COVID
11:25 am- 11.40 am	Speaker 6: Dr. Servio Ramirez, PhD, Department of Pathology and Laboratory Medicine, Center for Substance Abuse Research, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA Title: The SARS-CoV-2 spike protein triggers brain endothelial activation and negatively affects the function of the blood–brain barrier; implications for neuroinvasive mechanisms of emerging coronaviruses
Symposium 2: Therapeutic/vaccine approaches to COVID-19 Co-chairs: Dr. Nazira El-Hage, PhD, Associate Professor, School of Medicine, Florida International University, Miami, USA Dr. Yu (Woody) Lin, MD, PhD, Program Official, INB, DNB, NIDA, NIH, Bethesda, MD, USA
11:45 am- 12:00 pm	Speaker 1: Dr. Siddappa Byrareddy, PhD, Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA Title: Development of targeted therapeutics for COVID-19
12:00 pm- 12:15 pm	Speaker 2: Dr. Wen-Zhe Ho, MD, MPH, Department of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA Title: Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor
12:15 pm- 12:30 pm	Speaker 3: Dr. Rafal Kaminski, PhD, Center for Neurovirology/Department of Neuroscience, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA Title: Targeting N-glycosylation and palmitoylation pathways to block coronavirus infectivity
12:30 pm- 12:45 pm	Speaker 4: Dr. Bhavesh Kevadiya, PhD, Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA Title: Development of a layer-by-layer SARS-CoV-2 microparticle vaccine
12:45 pm- 1:00 pm	Speaker 5: Dr. Jag Khalsa, PhD, Formerly, Chief, Medical Consequences of Drug Abuse and Infections Branch, National Institute on Drug Abuse, NIH; Currently a Special Volunteer NIDA/NIH, Bethesda, MA, USA Dr. Sanjay Maggirwar, PhD, Department of Microbiology, Immunology, and Tropical Medicine, The George Washington School of Medicine and Health Sciences, Washington, DC, USA Dr. Gregory Bunt, MD, NYU and Samaritan Day Top Village Addiction Treatment Center, New York, NY, USA Title: COVID-19, cannabis/CBD, and the physician
1:00 pm- 1.15 pm	Speaker 6: Dr. Kalipada Pahan, PhD, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA Title: AIDS for COVID-19!
15-min break Symposium 3: Early career investigators (pre- and post-doctorate fellows) Co-chairs: Dr. Gurudutt Pendyala, PhD, Associate Professor, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA Dr. John Satterlee, PhD, Special Assistant to the DNB Director, Division of Neuroscience and Behavior (DNB), National Institute on Drug Abuse (NIDA), NIH, Bethesda, MD, USA
1:30 pm- 1:45 pm	Special talk: Dr. John Satterlee, PhD, Special Assistant to the DNB Director, DNB, NIDA, NIH, Bethesda, MD, USA Title: Opportunities from NIH for ECI fellows
1:45 pm- 1:53 pm	Speaker 1: Dr. Arpan Acharya, PhD, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA Title: HIV-1/SARS-CoV-2 coinfection and CNS pathogenesis
1:53 pm- 2:01 pm	Speaker 2: Liana Basova, BA, San Diego Biomedical Research Institute, La Jolla, CA, USA Title: Systems biology approaches detect early neuroinflammation and calcium signaling signatures in SARS-Cov-2 infection which are not affected by H1N1 in tracheal biopsies from the ferret model
2:01 pm- 2:09 pm	Speaker 3: Michael Mora Stangis, BA, Miller School of Medicine, University of Miami, FL, USA Title: Methamphetamine potentiates the S1 subunit of SARS-CoV-2 spike protein-induced downregulation of tight junction proteins of human brain endothelial cells
2:09 pm- 2:17 pm	Speaker 4: Dr. Silvia Torices, PhD, Miller School of Medicine, University of Miami, FL, USA Title: Expression of SARS-CoV-2-related receptors in naïve and HIV-1-infected cells of the neurovascular unit
2:17 pm- 2:25 pm	Panel discussion: Dr. Yisel Cantres-Rosario, PhD, Department of Microbiology and Medical Zoology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, USA
Symposium 4: Diversity and Inclusion SNIP Committee: Well-being and reflections Co-chairs: Dr. Sowmya Yelamanchili, PhD, Assistant Professor, Department of Anesthesiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA Dr. Jeymohan Joseph, PhD, Chief, HIV Neuropathogenesis, Genetics and Therapeutics Branch (HNGTB), Division of AIDS Research (DAR), National Institute of Mental Health (NIMH), Bethesda, MD, USA
2:30 pm- 2:45 pm	Special talk: Dr. Jeymohan Joseph, PhD, Chief, HNGTB, DAR, NIMH, Bethesda, MD, USA Title: Neurologic and psychiatric complications of SARS-CoV-2 infection
2:45 pm- 3:00 pm	Speaker 1: Dr. Thirumala-Devi Kanneganti, PhD, Immunology Department, St. Jude Children's Research Hospital, Memphis, TN, USA Title: Targeting innate immunity and inflammatory cell death, PANoptosis, for the treatment of COVID-19
3:00 pm- 3:15 pm	Speaker 2: Dr. Santosh Kumar, PhD, Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA Title: Intervention and improved well-being of basic science researchers during the COVID 19 era: a case study
3:15 pm- 3:55 pm	Panel discussion: Reflection and sharing Panelists: Drs. Jean Bidlack, Sylvia Fitting, Santhi Gorantla, Cecilia Marcondes, Loyda Melendez, Ilker Sariyer
3:55 pm	Conclusion